Dube Michael P
- SEC CIK
- 0002019493
In the past year, 3 open-market sale filings worth $104.4K and no purchases.
Current role at each company
- NTLA Intellia Therapeutics, Inc.VP, Chief Accounting Officeras of Jul 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $104.4K
- 3 filings
- Net
- −$104.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dube Michael P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 (view filing)5:02 PM ET | Jul 1 | 5 days | Dube Michael PVP, Chief Accounting Officer | SSale | −2.64K | $16.78 | −$44.3K | −3.8%66.9K after | |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Dube Michael PVP, Chief Accounting Officer | SSale | −2.99K | $9.21 | −$27.5K | −5.4%52.3K after | |
| Oct 3, 2025 (view filing) | Oct 1 | 2 days | Dube Michael PVP, Chief Accounting Officer | SSale | −1.87K | $17.38 | −$32.5K | −3.3%55.3K after | |
| Jul 3, 2025 (view filing) | Jul 2 | 1 day | Dube Michael PVP, Chief Accounting Officer | SSale | −2.50K | $9.95 | −$24.9K | −4.2%57.1K after | |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Dube Michael PVP, Chief Accounting Officer | SSale | −1.37K | $12.18 | −$16.7K | −2.9%45.6K after | |
| Oct 4, 2024 (view filing) | Oct 2 | 2 days | Dube Michael PVP, Chief Accounting Officer | SSale | −2.01K | $19.01 | −$38.2K | −4.1%47.0K after |